Catalyst Wire Dossier Catalyst Wire Dossier

NNC 0070-0002-0182

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC 0070-0002-0182, covering 2016-12-23 to 2016-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers [Phase 1]

See pricing